Publications Partners

Publications

Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, Sehmi JS, Gale DP, Wass MN, Ahmadi KR, Bakker SJ, Beckmann J, Bilo HJ, Bochud M, Brown MJ, Caulfield MJ, Connell JM, Cook HT, Cotlarciuc I, Smith GD, de Silva R, Deng G, Devuyst O, Dikkeschei LD, Dimkovic N, Dockrell M, Dominiczak A, Ebrahim S, Eggermann T, Farrall M, Ferrucci L, Floege J, Forouhi NG, Gansevoort RT, Han X, Hedblad B, van der Heide JJ, Hepkema BG, Hernandez-Fuentes M, Hypponen E, Johnson T, de Jong PE, Kleefstra N, Lagou V, Lapsley M, Li Y, Loos RJ, Luan J, Luttropp K, Maréchal C, Melander O, Munroe PB, Nordfors L, Parsa A, Peltonen L, Penninx BW, Perucha E, Pouta A, Prokopenko I, Roderick PJ, Ruokonen A, Samani NJ, Sanna S, Schalling M, Schlessinger D, Schlieper G, Seelen MA, Shuldiner AR, Sjögren M, Smit JH, Snieder H, Soranzo N, Spector TD, Stenvinkel P, Sternberg MJ, Swaminathan R, Tanaka T, Ubink-Veltmaat LJ, Uda M, Vollenweider P, Wallace C, Waterworth D, Zerres K, Waeber G, Wareham NJ, Maxwell PH, McCarthy MI, Jarvelin MR, Mooser V, Abecasis GR, Lightstone L, Scott J, Navis G, Elliott P, Kooner JS. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet. 2010; 42(5):373-5.

Verduijn M, Siegerink B, Jager KJ, Zoccali C, Dekker FW. Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol Dial Transplant. 2010;25:1394-98.

Molanaei H, Carrero JJ, Heimbürger O, Nordfors L, Lindholm B, Stenvinkel P, Odar-Cederlöf I, and Bertilsson L. The influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with chronic kidney disease. Eur J Clin Pharmacol. 2010;66:269-73.

Carrero JJ. Witasp A, Qureshi AR, Suliman ME, Schallin M, Barany P, Heimburger O, Norfors L, Lindholm B, Stenvinkel P, Axelsson J. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triacylglycerol levels. Nephrol Dial Transplant. 2010; 25:901-6.

Luttrop K, Lindholm B, Carrero JJ, Glorieux G, Vanholder R, Schalling M, Stenvinkel P, Nordfors L. Genetics in chronic kidney disease – towards personalized medicine! Semin Dial. 2009; 22:417-22.

Vegter S, Perna A, Hiddema W, Ruggenenti P, Remuzzi G, Navis G, Postma MJ. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism. Pharmacogenet Genomics. 2009; 19:695-703.

F.L.H. Muntinghe, M. Verduijn, M.W. Zuurman, D.C. Grootendorst, J.J. Carrero, A.R. Qureshi, K. Luttropp, L. Nordfors, B. Lindholm, V. Brandenburg, M. Schalling, P. Stenvinkel, E.W. Boeschoten, R.T. Krediet, G.J. Navis, F.W. Dekker, CC-chemokine receptor 5 deletion (CCR5delta32) protects against inflammation-associated mortality in dialysis patients. JASN 2009; 20(7):1641-9

Waaijenborg S, Zwinderman AH. Sparse canonical correlation analysis for identifying, connecting and completing gene-expression networks. BMC Bioinformatics, Sep. 2009

Fellström BC, Jardine AG, et al. AURORA Study Group.Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009 Apr 2;360(14):1395-407.

Ferreira JA, Berkhof J, Souverein O, Zwinderman K. A multiple testing approach to high-dimensional association studies with an application to the detection of associations between risk factors of heart disease and genetic polymorphisms. Stat Appl Genet Mol Biol. 2009 Jan;8(1):Article 7.

Chmielewski M, Stenvinkel P, Luttropp K, Suliman ME, Qureshi AR, Carrero JJ, Barany P, Heimburger O, Nordfors L, Lindholm B. LPL 1595 C/G and HL -480 C/T polymorphisms - impact on lipid profile in incident dialysis patients. Blood Purif. 2008; 26:555-560.

S. Vegter, C. Boersma, M. Rozenbaum, B. Wilffert, G.J. Navis, M.J. Postma, Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes; A Systematic Review on Content and Adherence to Guidelines. Pharmacoeconomics 2008; 26 (7): 569-587.

J.J. Carrero, P. Stenvinkel, B. Fellström, A.R. Qureshi, K. Lamb, O. Heimbürger, P. Bárány, K. Radhakrishnan, B. Lindholm, I. Soveri, L. Nordfors, P. G. Shiels, Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med 2008; 263:302-12.

K. Luttropp, P. Stenvinkel, J.J. Carrero, R. Pecoits-Filho, B. Lindholm, L. Nordfors, Understanding the role of genetic polymorphisms in chronic kidney disease. Pediatr Nephrol. 2008;23(11):1941-9.

Galindo Garr F, Zwinderman AH, Geskus RB, Sijpkens YWJ. A joint latent class changepoint model to improve the prediction of time to graft failure. J. R. Statist. Soc. A (2008) 171, Part 1, pp. 299–308

S. Kato, B. Lindholm, J. Axelsson, A.R. Qureshi, P. Barany, O. Heimbürger, J.A. Gustafsson, P. Stenvinkel P, L. Nordfors, Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients. Nephrol Dial Transplant. 2007 Sep;22(9):2571-7.

Seminara D, Khoury MJ, O'Brien TR, Manolio T, Gwinn ML, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam AP, Danesh J, Davey Smith G, Dolan S, Duncan R, Gruis NA, Hashibe M, Hunter D, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, Riboli E,Salanti G, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Ioannidis JP; Human Genome Epidemiology Network; the Network of Investigator Networks. The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology. 2007;18(1):1-8.

P.E.C. Brenchley, B. Lindholm, F.W. Dekker, G. Navis on behalf of the Renal Genome Network, Translating knowledge of the human genome into clinical practice in nephrology dialysis and transplantation: the renal genome network (ReGeNet). Nephrology Dialysis Transplantation 2006; 21:2681-2683.

Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter DJ, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, O'Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ; Human Genome Epidemiology Network and the Network of Investigator Networks. A road map for efficient and reliable human genome epidemiology. Nature Genetics 2006; 38:3-5.

Permanent link |

Print this page |

E-mail this page


Home About ReGeNet Membership Sponsors Projects GENECURE Partners Research Publications Login EPS Renal Biobank Catalogue Renal DataSHaPER Educational activities Links Contact Member login Regenet	Publications Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, Sehmi JS, Gale DP, Wass MN, Ahmadi KR, Bakker SJ, Beckmann J, Bilo HJ, Bochud M, Brown MJ, Caulfield MJ, Connell JM, Cook HT, Cotlarciuc I, Smith GD, de Silva R, Deng G, Devuyst O, Dikkeschei LD, Dimkovic N, Dockrell M, Dominiczak A, Ebrahim S, Eggermann T, Farrall M, Ferrucci L, Floege J, Forouhi NG, Gansevoort RT, Han X, Hedblad B, van der Heide JJ, Hepkema BG, Hernandez-Fuentes M, Hypponen E, Johnson T, de Jong PE, Kleefstra N, Lagou V, Lapsley M, Li Y, Loos RJ, Luan J, Luttropp K, Maréchal C, Melander O, Munroe PB, Nordfors L, Parsa A, Peltonen L, Penninx BW, Perucha E, Pouta A, Prokopenko I, Roderick PJ, Ruokonen A, Samani NJ, Sanna S, Schalling M, Schlessinger D, Schlieper G, Seelen MA, Shuldiner AR, Sjögren M, Smit JH, Snieder H, Soranzo N, Spector TD, Stenvinkel P, Sternberg MJ, Swaminathan R, Tanaka T, Ubink-Veltmaat LJ, Uda M, Vollenweider P, Wallace C, Waterworth D, Zerres K, Waeber G, Wareham NJ, Maxwell PH, McCarthy MI, Jarvelin MR, Mooser V, Abecasis GR, Lightstone L, Scott J, Navis G, Elliott P, Kooner JS. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet. 2010; 42(5):373-5. Verduijn M, Siegerink B, Jager KJ, Zoccali C, Dekker FW. Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol Dial Transplant. 2010;25:1394-98. Molanaei H, Carrero JJ, Heimbürger O, Nordfors L, Lindholm B, Stenvinkel P, Odar-Cederlöf I, and Bertilsson L. The influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with chronic kidney disease. Eur J Clin Pharmacol. 2010;66:269-73. Carrero JJ. Witasp A, Qureshi AR, Suliman ME, Schallin M, Barany P, Heimburger O, Norfors L, Lindholm B, Stenvinkel P, Axelsson J. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triacylglycerol levels. Nephrol Dial Transplant. 2010; 25:901-6. Luttrop K, Lindholm B, Carrero JJ, Glorieux G, Vanholder R, Schalling M, Stenvinkel P, Nordfors L. Genetics in chronic kidney disease – towards personalized medicine! Semin Dial. 2009; 22:417-22. Vegter S, Perna A, Hiddema W, Ruggenenti P, Remuzzi G, Navis G, Postma MJ. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism. Pharmacogenet Genomics. 2009; 19:695-703. F.L.H. Muntinghe, M. Verduijn, M.W. Zuurman, D.C. Grootendorst, J.J. Carrero, A.R. Qureshi, K. Luttropp, L. Nordfors, B. Lindholm, V. Brandenburg, M. Schalling, P. Stenvinkel, E.W. Boeschoten, R.T. Krediet, G.J. Navis, F.W. Dekker, CC-chemokine receptor 5 deletion (CCR5delta32) protects against inflammation-associated mortality in dialysis patients. JASN 2009; 20(7):1641-9 Waaijenborg S, Zwinderman AH. Sparse canonical correlation analysis for identifying, connecting and completing gene-expression networks. BMC Bioinformatics, Sep. 2009 Fellström BC, Jardine AG, et al. AURORA Study Group.Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009 Apr 2;360(14):1395-407. Ferreira JA, Berkhof J, Souverein O, Zwinderman K. A multiple testing approach to high-dimensional association studies with an application to the detection of associations between risk factors of heart disease and genetic polymorphisms. Stat Appl Genet Mol Biol. 2009 Jan;8(1):Article 7. Chmielewski M, Stenvinkel P, Luttropp K, Suliman ME, Qureshi AR, Carrero JJ, Barany P, Heimburger O, Nordfors L, Lindholm B. LPL 1595 C/G and HL -480 C/T polymorphisms - impact on lipid profile in incident dialysis patients. Blood Purif. 2008; 26:555-560. S. Vegter, C. Boersma, M. Rozenbaum, B. Wilffert, G.J. Navis, M.J. Postma, Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes; A Systematic Review on Content and Adherence to Guidelines. Pharmacoeconomics 2008; 26 (7): 569-587. J.J. Carrero, P. Stenvinkel, B. Fellström, A.R. Qureshi, K. Lamb, O. Heimbürger, P. Bárány, K. Radhakrishnan, B. Lindholm, I. Soveri, L. Nordfors, P. G. Shiels, Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med 2008; 263:302-12. K. Luttropp, P. Stenvinkel, J.J. Carrero, R. Pecoits-Filho, B. Lindholm, L. Nordfors, Understanding the role of genetic polymorphisms in chronic kidney disease. Pediatr Nephrol. 2008;23(11):1941-9. Galindo Garr F, Zwinderman AH, Geskus RB, Sijpkens YWJ. A joint latent class changepoint model to improve the prediction of time to graft failure. J. R. Statist. Soc. A (2008) 171, Part 1, pp. 299–308 S. Kato, B. Lindholm, J. Axelsson, A.R. Qureshi, P. Barany, O. Heimbürger, J.A. Gustafsson, P. Stenvinkel P, L. Nordfors, Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients. Nephrol Dial Transplant. 2007 Sep;22(9):2571-7. Seminara D, Khoury MJ, O'Brien TR, Manolio T, Gwinn ML, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam AP, Danesh J, Davey Smith G, Dolan S, Duncan R, Gruis NA, Hashibe M, Hunter D, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, Riboli E,Salanti G, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Ioannidis JP; Human Genome Epidemiology Network; the Network of Investigator Networks. The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology. 2007;18(1):1-8. P.E.C. Brenchley, B. Lindholm, F.W. Dekker, G. Navis on behalf of the Renal Genome Network, Translating knowledge of the human genome into clinical practice in nephrology dialysis and transplantation: the renal genome network (ReGeNet). Nephrology Dialysis Transplantation 2006; 21:2681-2683. Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter DJ, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, O'Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ; Human Genome Epidemiology Network and the Network of Investigator Networks. A road map for efficient and reliable human genome epidemiology. Nature Genetics 2006; 38:3-5.
	Permanent link \| Print this page \| E-mail this page
Copyright © 2007-2009 Hans Mak Instituut \| Disclaimer